4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000110
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 226,000 shares (grant or award)
From the SEC's structured data for this filing
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000110
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…